Vis børsmeldingen
THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE
APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS STOCK EXCHANGE
ANNOUNCEMENT.
Oslo, Norway - 28 February 2025 - Reference is made to the stock exchange
announcements from IDEX Biometrics ASA (the “Company”) dated 17 September and 2
December 2024 regarding the commencement of the exercise period for Warrants A
(ticker: IDEXJ), ISIN NO0013380048, issued in connection with the private
placement in September 2024 and subsequent offering in December 2024.
The exercise period for Warrants A will commence today, on 28 February 2025, and
ends on 13 March 2025 at 16:30 CET. Each Warrant gives the holder a right to
subscribe for one new share (“New Share”) in the Company at a subscription price
of NOK 0.15. All Warrants A not exercised within this period will lapse without
compensation to the holder. Warrants B may only be exercised from 31 March 2025
to 11 April 2025. Arctic Securities AS is acting as manager in connection with
the exercise of Warrants A (the “Manager”).
Exercise procedure
Warrants are exercised through the submission of a duly completed exercise form
for the Warrants (the “Exercise Form”) to the Manager at the address or email
address set out in the Prospectus and the Exercise Form and payment of the
aggregate subscription price for the New Shares. The Exercise Form can be found
at the websites of the Company (https://www.idexbiometrics.com/investors/), and
Arctic Securities AS (www.arctic.com/secno/en/offerings). By completing and
submitting an Exercise Form, the holder of the relevant Warrants irrevocably
undertakes to acquire a number New Shares equal to the number of Warrants
exercised at the relevant exercise price.
For more information relating to the Warrants, please refer to the Prospectus
approved and published by the Company on 13 November 2024.
For further information contact:
Marianne Bøe, Head of Investor Relations, +47 91800186
Kristian Flaten, CFO, +47 95092322
E-mail:ir@idexbiometrics.com (mailto:ir@idexbiometrics.com)
For information about the Warrants please contact the Manager:
Arctic Securities AS, tel.: + 47 21 01 30 40
About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint
biometrics, offering authentication solutions across payments, access control,
and digital identity. The company’s solutions provide convenience, security,
peace of mind, and seamless user experiences worldwide. Built on patented and
proprietary sensor technologies, integrated circuit designs, and software, IDEX
Biometrics’ biometric solutions target card-based applications for payments and
digital authentication. As an industry enabler, the company partners with
leading card manufacturers and technology companies to bring its solutions to
market.
For more information, please visit www.idexbiometrics.com
(https://www.idexbiometrics.com).
- IMPORTANT INFORMATION -
This announcement does not constitute an offer of securities for sale or a
solicitation of an offer to purchase securities of the Company in the United
States or any other jurisdiction. The securities of the Company may not be
offered or sold in the United States absent registration or an exemption from
registration under the U.S. Securities Act of 1933, as amended (the “U.S.
Securities Act”). The securities of the Company have not been, and will not be,
registered under the U.S. Securities Act. Any sale in the United States of the
securities mentioned in this communication will be made solely to “qualified
institutional buyers” as defined in Rule 144A under the U.S. Securities Act. No
public offering of the securities will be made in the United States.
This announcement has been prepared on the basis that any offer of securities in
any Member State of the European Economic Area, other than Norway, which has
implemented the Prospectus Regulation (EU) (2017/1129, as amended, the
“Prospectus Regulation”) (each, a “Relevant Member State”) will be made pursuant
to an exemption under the Prospectus Regulation, as implemented in that Relevant
Member State, from the requirement to publish a prospectus for offers of
securities. Accordingly any person making or intending to make any offer in that
Relevant Member State of securities which are the subject of the offering
contemplated in this announcement, may only do so in circumstances in which no
obligation arises for the Company or any of the Managers to publish a prospectus
pursuant to Article 3 of the Prospectus Regulation or supplement a prospectus
pursuant to Article 16 of the Prospectus Regulation, in each case, in relation
to such offer.
In the United Kingdom, this announcement is only addressed to and is only
directed at Qualified Investors who (i) are investment professionals falling
within Article 19(5) of the Financial Services and Markets Act 2000 (Financial
Promotion) Order 2005 (as amended) (the “Order”) or (ii) are persons falling
within Article 49(2)(a) to (d) of the Order (high net worth companies,
unincorporated associations, etc.) (all such persons together being referred to
as “Relevant Persons”). This announcement are directed only at Relevant Persons
and must not be acted on or relied on by persons who are not Relevant Persons.
Any investment or investment activity to which this announcement relates is
available only to Relevant Persons and will be engaged in only with Relevant
Persons. Persons distributing this communication must satisfy themselves that it
is lawful to do so.
Matters discussed in this announcement may constitute forward-looking
statements. Forward-looking statements are statements that are not historical
facts and may be identified by words such as “anticipate”, “believe”,
“continue”, “estimate”, “expect”, “intends”, “may”, “should”, “will” and similar
expressions. The forward-looking statements in this release are based upon
various assumptions, many of which are based, in turn, upon further assumptions.
Although the Company believes that these assumptions were reasonable when made,
these assumptions are inherently subject to significant known and unknown risks,
uncertainties, contingencies and other important factors which are difficult or
impossible to predict and are beyond its control. Such risks, uncertainties,
contingencies and other important factors could cause actual events to differ
materially from the expectations expressed or implied in this release by such
forward-looking statements. The information, opinions and forward-looking
statements contained in this announcement speak only as at its date, and are
subject to change without notice.
This announcement is made by and, and is the responsibility of, the Company. The
Manager is acting exclusively for the Company and no one else and will not be
responsible to anyone other than the Company for providing the protections
afforded to its respective clients, or for advice in relation to the contents of
this announcement or any of the matters referred to herein.
Neither the Manager nor any of its affiliates makes any representation as to the
accuracy or completeness of this announcement and none of them accepts any
responsibility for the contents of this announcement or any matters referred to
herein.
This announcement is for information purposes only and is not to be relied upon
in substitution for the exercise of independent judgment. It is not intended as
investment advice and under no circumstances is it to be used or considered as
an offer to sell, or a solicitation of an offer to buy any securities or a
recommendation to buy or sell any securities of the Company. Neither the Manager
nor any of its affiliates accepts any liability arising from the use of this
announcement. Any offering of the securities referred to in this announcement
will be made by means of a prospectus.
This announcement is an advertisement and is not a prospectus for the purposes
of the Prospectus Regulation. Investors should not subscribe for any securities
referred to in this announcement except on the basis of information contained in
the Prospectus dated 13 November 2024 and stock exchange announcements published
in connection with the private placement, subsequent offering and the Warrants.
Copies of the Prospectus is available from the Company’s registered office and,
subject to certain exceptions, on the websites of the Company
(www.idexbiometrics.com), Arctic Securities AS
(www.arctic.com/secno/en/offerings).
Each of the Company, the Manager and their respective affiliates expressly
disclaims any obligation or undertaking to update, review or revise any
statement contained in this announcement whether as a result of new information,
future developments or otherwise.
The distribution of this announcement and other information may be restricted by
law in certain jurisdictions. Persons into whose possession this announcement or
such other information should come are required to inform themselves about and
to observe any such restrictions.
This information is published in accordance with the requirements of the
Continuing Obligations.
Kilde
